December 3, 2025 · Form 4 insider transaction
Farnum Rhonda sold 15,534 shares of Theravance Biopharma, Inc. at $18.75 per share, a transaction worth $291.3K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.
This transaction was executed in multiple trades at prices from $18.52 to $18.94 The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.